title: Successful combination therapy with infusion of allogenetic bone marrow mesenchymal stem cells and CAG regimen in hypoplastic relapsed acute myelogenous leukemia.
authors.forename: Hua
authors.initials: H
authors.lastname: Lu
authors.forename: Shi-Feng
authors.initials: SF
authors.lastname: Lu
authors.forename: Wen-Yi
authors.initials: WY
authors.lastname: Shen
authors.forename: Ming
authors.initials: M
authors.lastname: Hong
authors.forename: Jian-Fu
authors.initials: JF
authors.lastname: Zhang
authors.forename: Li-Xia
authors.initials: LX
authors.lastname: Wang
authors.forename: Hui
authors.initials: H
authors.lastname: Yang
authors.forename: Jian-Yong
authors.initials: JY
authors.lastname: Li
mesh_terms: D015250:Aclarubicin / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001854:Bone Marrow Cells; D003561:Cytarabine / Q000627:therapeutic use; D005260:Female; D005434:Flow Cytometry; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000628:therapy*; D045164:Mesenchymal Stem Cell Transplantation; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis / Q000628:therapy*; D012074:Remission Induction; D014184:Transplantation, Homologous
chemical_list: D003561:Cytarabine; D016179:Granulocyte Colony-Stimulating Factor; D015250:Aclarubicin